A Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Immunological and Safety Parameters in Healthy Adults
Recombinant human lactoferrin (rhLF) is of commercial interest for immune support as a food ingredient. The objective was to evaluate the immunogenicity/alloimmunization potential of Helaina rhLF (effera™) from over a 28-day period compared to bovine LF (bLF). Study 1 was a randomized, double-blind,...
Saved in:
Published in | International journal of toxicology p. 10915818241293723 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
28.10.2024
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!